Hereditary cancer risk notification and testing: How interested is the general population?

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2139-2148

  Andrykowski, Michael A ^a   Lightner, Robin ^a   Studts, Jamie L ^a   Munn, Rita K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC RISK; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH SURVEY; HETEROZYGOTE; HUMAN; INTERVIEW; MALE; MENTAL HEALTH; NORMAL HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE;

EID: 0030912491     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2139     Document Type: Article

References (32)

1. Narod SA: Screening for cancer in high risk families. Clin Biochem 28:367-372, 1995
2. Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689, 1990
3. Easton DF, Bishop DT, Ford D, et al: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678-701, 1993
4. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
5. Leach FS, Nicolaides N, Papadopoulos N, et al: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1235, 1993
6. Powell S, Petersen G, Krush AJ, et al: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982-1987, 1993
7. Wiggs J, Nordenskjold M, Yandell D, et al: Prediction of the risk of hereditary retinoblastoma using DNA polymorphisms within the retinoblastoma gene. N Engl J Med 318:151-157, 1988
8. Whelan AJ, Bartsch D, Goodfellow PJ: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor suppressor gene. N Engl J Med 333:975-977, 1995
9. Wells SA, Chi DD, Toshima K, et al: Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia Type 2A. Ann Surg 220:237-250, 1994
10. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990
11. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision-making and outcomes. JAMA 275:1885-1892, 1996
12. Lerman C, Audrain J, Croyle RT: DNA-testing for heritable breast cancer risks: Lessons from traditional genetic counseling. Ann Beh Med 16:327-333, 1994
13. Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: Psychosocial and ethical implications. J Clin Oncol 9:1275-1282, 1991
14. Croyle RT, Lerman C: Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 22:284-292, 1993
15. Lerman C, Marshall J, Audrain J, et al: Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 69:58-61, 1996
16. Smith KR, Croyle RT: Attitudes toward genetic testing for colon cancer risk. Am J Pub Health 85:1435-1438, 1995
17. Andrykowski MA, Munn RK, Studts JL: Interest in learning of a personal genetic predisposition for cancer: Results of a general population survey. Prev Med 25:527-536, 1996
18. Chaliki H, Loader S, Levenkron JC, et al: Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Pub Health 85:1133-1135, 1995
19. Croyle RT, Dutson DS, Tran VT, et al: Need for certainty and interest in genetic testing. Wom Health Res Gender Behavior Policy 1:329-333, 1995
20. Lerman C, Daly M, Masny A, et al: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850, 1994
21. Lerman C, Seay J, Balshem A, et al: Interest in genetic testing among first degree relatives of breast cancer patients. Am J Med Genet 57:385-392, 1995
22. Struewing JP, Lerman C, Kase RG, et al: Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidem Biomark Prev 4:169-173, 1995
23. Watson M, Lloyd SM, Eeles R, et al: Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting. Psycho Oncol 5:233-239,1996
24. Prochaska JO, DiClemente CO, Norcross JC: In search of how people change: Applications to addictive behaviors. Am Psychol 47:1102-1114, 1992
25. Bruhn JG: Life-style and health behavior, in DS Gochman (ed): Health Behavior: Emerging Research Perspectives. New York, NY, Plenum, 1988, pp 71-86
26. Kulik JA, Mahler HIM: Health status, perceptions of risk, and prevention interest for health and nonhealth problems. Health Psych 6:15-27, 1987
27. Stewart AL, Hays RD, Ware JE Jr: The MOS Short-Form General Health Survey: Reliability and validity in a patient population. Med Care 26:724-735, 1988
28. Wright JW (ed): The Universal Almanac. Kansas City, MO, Andrews & McMeel, 1993
29. US Bureau of the Census: Statistical Abstract of the United States. Washington, DC, US Bureau of the Census, 1995
30. American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736, 1996
31. Crauford D, Kerzin-Starrar L, Dodge A, et al: Uptake of presymptomatic predictive testing for Huntington's Disease. Lancet 21:603-605, 1989
32. Patenaude AF, Schneider KA, Kieffer SA, et al: Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing. Psycho Oncol 5:241-250, 1996